Table 1.
Patient demographics and baseline characteristics (n = 83)
| Patient characteristics | N | % |
|---|---|---|
| Median age (range) | 68 | (31–93) |
| Sex | ||
| - male | 47 | 57 |
| - female | 36 | 43 |
| ECOG | ||
| - 0 | 49 | 59 |
| - 1 | 24 | 29 |
| - 2 | 10 | 12 |
| Stage | ||
| - IV | 62 | 75 |
| - III inoperable | 21 | 25 |
| Adjuvant chemotherapy | 8 | 9.6 |
| Stage III | n = 21 | 100% |
| Chemoradiation for locally advanced disease | 7 | 33.3 |
| Stage IV | n = 62 | 100% |
| Metastatic sites at start of first palliative CHT | ||
| - Liver | 40 | 64.5 |
| - Lung | 15 | 24.2 |
| - Peritoneum | 14 | 22.6 |
| - Bone | 3 | 4.8 |
| - Other | 4 | 6.5 |
| Number of metastatic sites | ||
| - 1 | 50 | 80.6 |
| - ≥ 2 | 12 | 19.4 |
| CA 19.9 (U/l) | ||
| - Median (range) | 1363 | (0–328,209) |
| - ≤ 37 | 14 | 16.9 |
| - ≥ 37 | 69 | 83.1 |